Abstract
In the Federal Republic of Germany three consecutive multicenter studies on childhood Hodgkin’s disease have been undertaken since 1978 (Brämswig et al. 1987; Breu et al. 1982; Schellong et al. 1985, 1986a, b, c). Up to 1987 more than 500 children under the age of 16 years have been treated in these studies at more than 60 centers, including some hospitals in Austria and The Netherlands.
Supported by the Bundesminister für Forschung und Technologie of the Federal Republic of Germany.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brämswig JH, Heermann E, Heimes U, Schlegel W, Nieschlag E, Schellong G (1987) Testicular function in boys treated for Hodgkin’s disease: results of a longitudinal and cross-sectional study in 52 postpubertal boys (abstr). Acta Endocrinol (Copenh) 114: 20
Breu H, Schellong G, Grosch-Wörner I, Jobke A, Riehm H, Treuner J. Schwarze EW, Wannenmacher M (1982) Abgestufte Chemotherapie und reduzierte Strahlendosis beim Morbus Hodgkin im Kindesalter-Ein Bericht über 170 Patienten der kooperativen Therapiestudie HD-78. Klin Pädiatr 194: 233–241
Schellong G, Strauch ST, Waubke AK, Brandeis W, Pawlowsky J, Schwarze EW, Riehm H, Langermann HJ, Wannenmacher M (1985) Combined modality treatment with reduced chemotherapy and radiotherapy, and selective splenectomy, in children with Hodgkin’s disease. In: Cavalli F, Bonnadonna G, Rozencweig M (eds) Malignant lymphomas and Hodgkin’s disease. Experimental and therapeutic advances. Martinus Nijhoff, The Hague, pp 617–626
Schellong G, Waubke-Landwehr AK, Langermann HJ, Riehm HJ, Brämswig J, Ritter J (1986a) Prediction of splenic involvement in children with Hodgkin’s disease. Significance of clinical and intraoperative findings. A retrospective statistical analysis of 154 patients in the German therapy study DAL-HD-78. Cancer 57: 2049–2056
Schellong G, Brämswig J, Ludwig R, Gerein V, Jobke A, Jürgens H, Kabisch H, Stollmann B, Weinel P, Gadner H, Schwarze EW, Wannenmacher M (1986b) Kombinierte Behandlungsstrategie bei über 200 Kindern mit Morbus Hodgkin: Abgestufte Chemotherapie, Involved-Field-Bestrahlung mit erniedrigten Dosen und selektiver Splenektomie. Ein Bericht der kooperativen Therapiestudie DAL-HD-82. Klin Pädiatr 198: 137–146
Schellong G, Lietzke S, Strauch ST, Kuhne B, Schneider B (1986c) Bedeutung sonographischer, computertomographischer und klinischer Befunde für die Erkennung eines Abdominalbefalls beim Morbus Hodgkin im Kindesalter-Eine retrospektive statistische Analyse bei 145 Patienten der Therapiestudie DAL-HD-82. Klin Pädiatr 198: 147–154
Schellong G, Hörnig I, Brämswig J, Bökkerink JPM, Steinhoff A, Ludwig R, Niethammer D, Reiter A, von Lengerke HJ, Heinecke H, Schwarze EW, Pötter R, Müller RP, Wannenmacher M (1988) Zur Bedeutung des Procarbazins in der Chemotherapie des Morbus Hodgkin-Ein Bericht der kooperativen Therapiestudie DAL-HD-85. Klin Pädiatr 200: 205–213
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Schellong, G., Hörnig, I., Schwarze, E.W., Wannenmacher, M. (1989). Risk Factor Adapted Treatment of Hodgkin’s Lymphoma in Childhood: Strategies and Results of Three Consecutive Multicenter Studies in the Federal Republic of Germany. In: Diehl, V., Pfreundschuh, M., Loeffler, M. (eds) New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease. Recent Results in Cancer Research, vol 117. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83781-4_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-83781-4_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83783-8
Online ISBN: 978-3-642-83781-4
eBook Packages: Springer Book Archive